Page 8 - J Amp News Today

The patent would have extended J&J's monopoly on the anti-TB drug in India. But with this judgment, generic manufacturers can now make their own versions at an affordable price from this year.

The U.S. Third Circuit Court of Appeals in Philadelphia has dismissed a Chapter 11 petition filed by a recently created subsidiary of Johnson & Johnson (J&J) called LTL Management, which [...]

(Reuters) -A U.S. appeals court upended Johnson & Johnson's attempt to offload into bankruptcy tens of thousands of lawsuits over its talc products, ruling the healthcare conglomerate improperly placed a subsidiary into Chapter 11 proceedings even though it did not face financial distress. The decision by the U.S. 3rd Circuit Court of Appeals in Philadelphia on Monday dismissed a Chapter 11 petition filed by a recently created J&J subsidiary in October to address more than 38,000 l...

Johnson & Johnson on Tuesday said it sees the impact from high inflation carrying into 2023 and expects Chinas major COVID-19 outbreak to dent sales at its medical devices unit in the first half of

Johnson & Johnson beat earnings expectations in the final quarter of 2022 even as a strong dollar and ...

The only HIV vaccine currently in late-stage trials, which was developed by J&J, has been discarded after tests showed that it was ineffective against the virus.

Lititz plant to become part of a spin off company.

The Japan unit of U.S. pharmaceutical giant Johnson & Johnson and a Tokyo-based firm selling medical products have been searched by the country's antitrust watchdog over potential violations of the antimonopoly law, sources close to the matter say.

Elon Musk's company has lost almost a Berkshire Hathaway's worth of market value, or more than the combined worth of Coca-Cola and PepsiCo.

Johnson & Johnson announced Tuesday its purchase of heart pump company Abiomed in a $16.6B cash deal.